Healthcare provider profile · identity verified

Veronica M Banta, MD

Family Practice · LOS ANGELES, CA · NPI 1265692925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	703	235
Amlodipine Besylate	Amlodipine Besylate	274	95
Losartan Potassium	Losartan Potassium	261	88
Metformin Hcl	Metformin Hcl	260	90
Levothyroxine Sodium	Levothyroxine Sodium	241	80
Valsartan	Valsartan	225	73
Rosuvastatin Calcium	Rosuvastatin Calcium	220	79
Gabapentin	Gabapentin	201	84
Carvedilol	Carvedilol	163	54
Metoprolol Succinate	Metoprolol Succinate	162	44
Omeprazole	Omeprazole	142	64
Lisinopril	Lisinopril	133	43
Irbesartan	Irbesartan	128	42
Duloxetine Hcl	Duloxetine Hcl	122	45
Pantoprazole Sodium	Pantoprazole Sodium	97	37
Olmesartan Medoxomil	Olmesartan Medoxomil	92	32
Trazodone Hcl	Trazodone Hcl	89	31
Hydralazine Hcl	Hydralazine Hcl	86	34
Pravastatin Sodium	Pravastatin Sodium	85	34
Ibandronate Sodium	Ibandronate Sodium	83	30
Famotidine	Famotidine	74	27
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	72	17
Albuterol Sulfate Hfa	Albuterol Sulfate	71	30
Simvastatin	Simvastatin	64	22
Alendronate Sodium	Alendronate Sodium	63	30
Glipizide	Glipizide	54	19
Tamsulosin Hcl	Tamsulosin Hcl	54	21
Fluoxetine Hcl	Fluoxetine Hcl	51	20
Benazepril Hcl	Benazepril Hcl	48	14
Januvia	Sitagliptin Phosphate	47	16
Lovastatin	Lovastatin	46	14
Meclizine Hcl	Meclizine Hcl	46	27
Metoprolol Tartrate	Metoprolol Tartrate	42	13
Vitamin D2	Ergocalciferol (Vitamin D2)	40	19
Atenolol	Atenolol	39	14
Fluticasone Propionate	Fluticasone Propionate	39	17
Quetiapine Fumarate	Quetiapine Fumarate	39	12
Glimepiride	Glimepiride	38	13
Jardiance	Empagliflozin	38	13
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Pioglitazone Hcl	Pioglitazone Hcl	37	13
Clopidogrel	Clopidogrel Bisulfate	34	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	27
Eliquis	Apixaban	31	13
Furosemide	Furosemide	30	17
Montelukast Sodium	Montelukast Sodium	30	12
Donepezil Hcl	Donepezil Hcl	28	suppressed
Finasteride	Finasteride	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	15
Ezetimibe	Ezetimibe	25	11
Metformin Hcl Er	Metformin Hcl	25	suppressed
Xarelto	Rivaroxaban	25	12
Chlorthalidone	Chlorthalidone	24	suppressed
Methylprednisolone	Methylprednisolone	23	20
Allopurinol	Allopurinol	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Propranolol Hcl	Propranolol Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Naproxen	Naproxen	19	14
Baclofen	Baclofen	18	13
Hydrocortisone	Hydrocortisone	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Spironolactone	Spironolactone	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error